Recombinant megakaryocyte growth and development factor - Biology and potential clinical applications

被引：0
|
作者：
Barge, AJ [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
PLATELETS | 1997年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：446 / 446
页数：1
相关论文
共 50 条
  • [31] Long-term efficacy of pegylated recombinant human megakaryocyte growth and development factor in therapy of aplastic anemia
    Yonemura, Y
    Miyake, H
    Asou, N
    Mitsuya, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (04) : 307 - 309
  • [32] Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice
    Kabaya, K
    Shibuya, K
    Torii, Y
    Nitta, Y
    Ida, M
    Akahori, H
    Kato, T
    Kusaka, M
    Miyazaki, H
    BONE MARROW TRANSPLANTATION, 1996, 18 (06) : 1035 - 1041
  • [33] Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor
    Harker, LA
    Marzec, UM
    Novembre, F
    Sundell, IB
    Waller, EK
    Karpatkin, S
    McClure, HM
    Kelly, AB
    Stead, RB
    BLOOD, 1998, 91 (12) : 4427 - 4433
  • [34] Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice
    Shibuya, K
    Akahori, H
    Takahashi, K
    Tahara, E
    Kato, T
    Miyazaki, H
    BLOOD, 1998, 91 (01) : 37 - 45
  • [35] Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
    Yuji Yonemura
    Hirosada Miyake
    Norio Asou
    Hiroaki Mitsuya
    International Journal of Hematology, 2005, 82 : 307 - 309
  • [36] THE STRUCTURE, BIOLOGY AND POTENTIAL THERAPEUTIC APPLICATIONS OF RECOMBINANT THROMBOPOIETIN
    LOK, S
    FOSTER, DC
    STEM CELLS, 1994, 12 (06) : 586 - 598
  • [37] Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression
    Coleman, D
    Fairchild, D
    Schindler-Horvat, J
    Munyakazi, L
    Neumann, TAK
    TOXICOLOGICAL SCIENCES, 1998, 45 (01) : 77 - 87
  • [38] Thrombopoietin: Biology and potential clinical applications
    Prow, D
    Vadhan-Raj, S
    ONCOLOGY-NEW YORK, 1998, 12 (11): : 1597 - +
  • [39] A model for studying megakaryocyte development and biology
    Murphy, GJ
    Leavitt, AD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 3065 - 3070
  • [40] The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis
    Choi, ES
    Hokom, MM
    Chen, JL
    Skrine, J
    Faust, J
    Nichol, J
    Hunt, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (02) : 227 - 233
12345